Back
Brasilagro - Cia Bras de Prop Agricolas 10K Form
Sell
44
LND
Brasilagro - Cia Bras de Prop Agricolas
Last Price:
4.08
Seasonality Move:
2.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LND News And Ratings
See the #1 stock for the next 7 days that we like better than LND
LND Financial Statistics
Sales & Book Value
| Annual Sales: | $203.81M |
|---|---|
| Cash Flow: | $-4.72M |
| Price / Cash Flow: | 149.23 |
| Annual Sales: | $4.19 |
| Price / Book: | 0.98 |
Profitability
| EPS (TTM): | 0.53550 |
|---|---|
| Net Income (TTM): | $54.99M |
| Gross Margin: | $62.42M |
| Return on Equity: | 13.33% |
| Return on Assets: | 8.13% |
Brasilagro - Cia Bras de Prop Agricolas Earnings Forecast
Key Brasilagro - Cia Bras de Prop Agricolas Financial Ratios
- The Gross Profit Margin over the past 18 years for LND is 30.63%.
- The Selling, General & Administrative Expenses for LND have been equal to 9.99% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 29.63% of Operating Income.
- The Net Earning history of LND is 22.28% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 8 years.
Brasilagro - Cia Bras de Prop Agricolas Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Food Products |
| Sector: | Consumer Staples |
| Current Symbol: | LND |
| CUSIP: | 10554B |
| Website: | ri.brasil-agro.com |
Debt
| Debt-to-Equity Ratio: | 0.32 |
|---|---|
| Current Ratio: | 2.01 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.01 |
|---|---|
| Forward P/E Ratio: | 0 |
LND Technical Analysis vs Fundamental Analysis
Sell
44
Brasilagro - Cia Bras de Prop Agricolas (LND)
is a Sell
Is Brasilagro - Cia Bras de Prop Agricolas a Buy or a Sell?
-
Brasilagro - Cia Bras de Prop Agricolas stock is rated a Sell
The current Brasilagro - Cia Bras de Prop Agricolas [LND] share price is $4.08. The Score for LND is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.